News in brief: Cannaponics raise tops $2.5m; Avecho receives $1.98m R&D incentive; Elixinol backs capital raising plans by Adam Sheldon May 27, 2026May 28, 2026 Cannaponics’ capital raise on OnMarket has attracted more than $2.5 million from almost 1,300 investors ahead […]
Avecho prepares for potentially ‘transformative’ CBD trial results by Adam Sheldon March 4, 2026March 5, 2026
News in brief: ANZCCP elects new president; extra sites for Avecho CBD trial; Cann Group’s R&D tax advance by Steve Jones April 30, 2025April 30, 2025
Company news: Rua Bioscience; Avecho; Bioxyne/BLS; iX Biopharma; Ecofibre; Zelira by Steve Jones and Martin Lane August 28, 2024January 13, 2025
Company news: Avecho; Bioxyne; Elixinol Wellness; IDT Australia; Melodiol Global Health; Zelira by Steve Jones July 31, 2024November 25, 2024
Quarterly results: Avecho; Melodiol; Bioxyne/BLS; Emyria; Ecofibre; Zelira; Elixinol; AusCann; Botanix by Steve Jones and Martin Lane January 31, 2024July 11, 2024
Avecho looks to Authorised Prescribers to find optimal dose for new fast-onset THC gummies by Steve Jones August 9, 2023August 21, 2023
CBD stability boost for Avecho ahead of insomnia clinical trial by Steve Jones June 23, 2023April 30, 2024
Avecho chief warns of placebo dangers as firms roll out CBD clinical trials by Steve Jones October 20, 2022April 29, 2024
